Literature DB >> 19758250

Is diagnostic delay related to advanced-stage oral cancer? A meta-analysis.

Iria Gómez1, Juan Seoane, Pablo Varela-Centelles, Pedro Diz, Bahi Takkouche.   

Abstract

Diagnostic delay in oropharyngeal cancer may be associated with poor prognosis. As controversy exists on this topic because of contradictory results, the aim of this study was to perform a systematic review of the relationship between total diagnostic delay and advanced disease stages. A systematic search of MEDLINE, EMBASE, and ISI proceedings was made to identify observational studies that provided relative risks (RRs) and 95% confidence intervals (CIs) for patients with confirmed pathological diagnosis. The outcome of interest was disease stage (TNM classification), while the exposure of interest was the total diagnostic delay. The study-specific adjusted log RRs for cohort studies were weighted by the inverse of their variance to compute a pooled RR and its 95% CI. The fixed-effects pooled RR of advanced stages of oropharyngeal cancer when diagnostic delay is present was 1.32 (95% CI: 1.07-1.62). This association was stronger when the analysis was restricted to oral cancer (pooled RR: 1.47; 95% CI: 1.09-1.99) and when delay was longer than 1 month (pooled RR: 1.69; 95% CI: 1.26-2.77). The probability for patients with delayed diagnosis to present an advanced-stage tumour at diagnosis was significantly higher than that of patients with no delay in diagnosis. However, new prospective studies with strict methodology are needed to shed more light on this association.

Entities:  

Mesh:

Year:  2009        PMID: 19758250     DOI: 10.1111/j.1600-0722.2009.00672.x

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  27 in total

1.  Total diagnostic delay in oral cancer may be related to advanced disease stage at diagnosis.

Authors:  Jennifer L Cleveland; Gina Thornton-Evans
Journal:  J Evid Based Dent Pract       Date:  2012-06       Impact factor: 5.267

2.  Mutations in p53 Gene Exons in a Sample from the South of Spain in Oral Cancer.

Authors:  Guiomar Martín-Lozano; Raquel Gómez-Díaz; Fernando Iglesías-Martín; Daniel Torres-Lagares; Aida Gutiérrez-Corrales; José-Luis Gutiérrez-Pérez
Journal:  J Clin Exp Dent       Date:  2021-10-01

3.  Disparities in Survival Patterns for Oral and Pharyngeal Cancer in Florida: Can We Do Anything about It?

Authors:  Henrietta L Logan; Yi Guo; John Marks
Journal:  Todays FDA       Date:  2015 May-Jun

4.  Diagnosis and referral delays in primary care for oral squamous cell cancer: a systematic review.

Authors:  Ciaran Grafton-Clarke; Kai Wen Chen; Jane Wilcock
Journal:  Br J Gen Pract       Date:  2018-11-19       Impact factor: 5.386

Review 5.  Oral premalignancy: the roles of early detection and chemoprevention.

Authors:  Jean-Philippe Foy; Chloé Bertolus; William N William; Pierre Saintigny
Journal:  Otolaryngol Clin North Am       Date:  2013-05-25       Impact factor: 3.346

6.  Diagnostic Pathway of Oral Cavity Cancer in an Integrated Health Care System.

Authors:  Kevin H Wang; Brian H Song; Jason E Gilde; Jeanne A Darbinian; Miranda L Ritterman Weintraub; Tara J Wu; Eleanor L Yang; James W Salazar; Deepak Gurushanthaiah
Journal:  Perm J       Date:  2018

7.  Factors related to late stage diagnosis of oral squamous cell carcinoma.

Authors:  Juan-Manuel Seoane-Romero; Inés Vázquez-Mahía; Juan Seoane; Pablo Varela-Centelles; Inmaculada Tomás; José-Luis López-Cedrún
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-01-01

8.  Quantitative risk stratification of oral leukoplakia with exfoliative cytology.

Authors:  Yao Liu; Jianying Li; Xiaoyong Liu; Xudong Liu; Waqaar Khawar; Xinyan Zhang; Fan Wang; Xiaoxin Chen; Zheng Sun
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

Review 9.  Advances in optical adjunctive AIDS for visualisation and detection of oral malignant and potentially malignant lesions.

Authors:  Nirav Bhatia; Yastira Lalla; An N Vu; Camile S Farah
Journal:  Int J Dent       Date:  2013-09-02

10.  Beyond tobacco in head and neck squamous cell cancers… Emerging era of molecular targeted therapy and virtual biopsy.

Authors:  Ravi Kant
Journal:  Natl J Maxillofac Surg       Date:  2015 Jan-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.